{"items": "111", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Biostimulants Market Size Set to Soar to USD 62.9 Billion by 2031 at a CAGR of 9.6%, Offering Strategic Opportunities in Agri-Business: Report from Transparency Market Research, Inc.", "url": "https://www.benzinga.com/pressreleases/24/08/g40192859/biostimulants-market-size-set-to-soar-to-usd-62-9-billion-by-2031-at-a-cagr-of-9-6-offering-strate", "time_published": "20240806T145241", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, Transparency Market Research Inc., Aug. 06, 2024 ( GLOBE NEWSWIRE ) -- The global biostimulants market ( \uc0dd\ubb3c \uc790\uadf9\uc81c \uc2dc\uc7a5 ) was valued at US$ 27.6 Bn in 2022.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.26732, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.03642", "ticker_sentiment_score": "0.045614", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.03642", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOMMF", "relevance_score": "0.03642", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.03642", "ticker_sentiment_score": "0.182208", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WMGTF", "relevance_score": "0.108958", "ticker_sentiment_score": "0.08558", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.03642", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Top Trends in the Agricultural Biologicals Market to Hit $27.9 billion by 2028", "url": "https://www.benzinga.com/pressreleases/24/08/g40191269/top-trends-in-the-agricultural-biologicals-market-to-hit-27-9-billion-by-2028", "time_published": "20240806T140000", "authors": ["Globe Newswire"], "summary": "Chicago, Aug. 06, 2024 ( GLOBE NEWSWIRE ) -- According to a research report top trends in the agricultural biologicals market is projected to grow at a CAGR of 13.7% from an estimated value of USD 14.7 billion in 2023 to reach USD 27.9 billion by 2028.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.269091, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.060848", "ticker_sentiment_score": "0.045", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAYZF", "relevance_score": "0.121343", "ticker_sentiment_score": "0.15161", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Now Covered by StockNews.com", "url": "https://www.defenseworld.net/2024/07/13/evogene-nasdaqevgn-now-covered-by-stocknews-com.html", "time_published": "20240713T052649", "authors": ["Defense World Staff"], "summary": "StockNews.com started coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a research note issued on Saturday. The brokerage set a \"sell\" rating on the biotechnology company's stock. Evogene stock opened at $0.64 on Friday. Evogene has a 1 year low of $0.45 and a 1 year high of ...", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.796627"}], "overall_sentiment_score": 0.152493, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.926237", "ticker_sentiment_score": "0.267832", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.157483", "ticker_sentiment_score": "-0.046874", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/07/05/evogene-nasdaqevgn-earns-sell-rating-from-analysts-at-stocknews-com-2.html", "time_published": "20240705T051046", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com started coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a report released on Friday. The firm set a \"sell\" rating on the biotechnology company's stock. Evogene stock opened at $0.64 on Friday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.157147, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.931897", "ticker_sentiment_score": "0.276188", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AWON", "relevance_score": "0.160633", "ticker_sentiment_score": "-0.05012", "ticker_sentiment_label": "Neutral"}]}, {"title": "Lavie Bio Announces Commercial Expansion of Yalos\u2122 to Winter Wheat - PR Newswire", "url": "https://www.prnewswire.com/news-releases/lavie-bio-announces-commercial-expansion-of-yalos-to-winter-wheat-302187839.html", "time_published": "20240702T110000", "authors": [], "summary": "Lavie Bio Announces Commercial Expansion of Yalos\u2122 to Winter Wheat PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.237596, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.567144", "ticker_sentiment_score": "0.229127", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/06/27/evogene-nasdaqevgn-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20240627T183021", "authors": ["Defense World Staff"], "summary": "Equities research analysts at StockNews.com started coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a report released on Thursday. The brokerage set a \"sell\" rating on the biotechnology company's stock. Evogene stock opened at $0.64 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.818451"}], "overall_sentiment_score": 0.096468, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.933751", "ticker_sentiment_score": "0.171709", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENVX", "relevance_score": "0.16171", "ticker_sentiment_score": "0.100955", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Earns Sell Rating from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/06/19/evogene-nasdaqevgn-earns-sell-rating-from-analysts-at-stocknews-com.html", "time_published": "20240619T051846", "authors": ["Defense World Staff"], "summary": "Equities researchers at StockNews.com initiated coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a research report issued on Wednesday. The firm set a \"sell\" rating on the biotechnology company's stock. EVGN opened at $0.64 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.207849, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.902368", "ticker_sentiment_score": "0.356819", "ticker_sentiment_label": "Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/06/11/evogene-nasdaqevgn-coverage-initiated-by-analysts-at-stocknews-com-2.html", "time_published": "20240611T120549", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com began coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a note issued to investors on Tuesday. The brokerage set a \"sell\" rating on the biotechnology company's stock. Shares of NASDAQ EVGN opened at $0.67 on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.929393"}], "overall_sentiment_score": 0.281976, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.891347", "ticker_sentiment_score": "0.47135", "ticker_sentiment_label": "Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Coverage Initiated by Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/06/03/evogene-nasdaqevgn-coverage-initiated-by-analysts-at-stocknews-com.html", "time_published": "20240603T053653", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com started coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a research note issued on Monday. The firm set a \"sell\" rating on the biotechnology company's stock. Shares of EVGN stock opened at $0.75 on Monday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.857896"}], "overall_sentiment_score": 0.120018, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.868543", "ticker_sentiment_score": "0.207845", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COST", "relevance_score": "0.1331", "ticker_sentiment_score": "0.091352", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWON", "relevance_score": "0.1331", "ticker_sentiment_score": "0.001204", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/05/26/evogene-nasdaqevgn-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20240526T052253", "authors": ["Defense World Staff"], "summary": "Research analysts at StockNews.com started coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a report released on Sunday. The brokerage set a \"sell\" rating on the biotechnology company's stock. Shares of EVGN opened at $0.82 on Friday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.917436"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.12926, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.881404", "ticker_sentiment_score": "0.224626", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene Reports First Quarter 2024 Financial Results", "url": "https://www.prnewswire.com/il/news-releases/evogene-reports-first-quarter-2024-financial-results-302154117.html", "time_published": "20240523T110000", "authors": ["Evogene"], "summary": "Conference call and webcast: today, May 23, 2024, 9:00 am ET \u2022 Q1 2024 revenue: vs. in Q1 2023.", "banner_image": "https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.244067, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.412579", "ticker_sentiment_score": "0.310486", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTVA", "relevance_score": "0.107898", "ticker_sentiment_score": "0.105537", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERGF", "relevance_score": "0.018037", "ticker_sentiment_score": "0.116891", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLJF", "relevance_score": "0.018037", "ticker_sentiment_score": "0.183539", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "StockNews.com Initiates Coverage on Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.defenseworld.net/2024/05/18/stocknews-com-initiates-coverage-on-evogene-nasdaqevgn.html", "time_published": "20240518T074047", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com began coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a note issued to investors on Saturday. The brokerage set a \"sell\" rating on the biotechnology company's stock. Shares of Evogene stock opened at $0.66 on Friday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Manufacturing", "relevance_score": "0.5"}, {"topic": "Earnings", "relevance_score": "0.967321"}], "overall_sentiment_score": 0.159851, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.887767", "ticker_sentiment_score": "0.276384", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMAT", "relevance_score": "0.140076", "ticker_sentiment_score": "0.178552", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Research Coverage Started at StockNews.com", "url": "https://www.defenseworld.net/2024/05/10/evogene-nasdaqevgn-research-coverage-started-at-stocknews-com.html", "time_published": "20240510T075652", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com initiated coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a report issued on Friday. The brokerage set a \"sell\" rating on the biotechnology company's stock. EVGN stock opened at $0.70 on Friday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.947132"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.096416, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.872847", "ticker_sentiment_score": "0.167994", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RBLX", "relevance_score": "0.13459", "ticker_sentiment_score": "0.067492", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.13459", "ticker_sentiment_score": "0.067492", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Receives New Coverage from Analysts at StockNews.com", "url": "https://www.defenseworld.net/2024/05/06/evogene-nasdaqevgn-receives-new-coverage-from-analysts-at-stocknews-com.html", "time_published": "20240506T203226", "authors": ["Defense World Staff"], "summary": "StockNews.com initiated coverage on shares of Evogene ( NASDAQ:EVGN - Free Report ) in a report published on Thursday. The brokerage issued a sell rating on the biotechnology company's stock. Shares of EVGN stock opened at $0.71 on Thursday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}], "overall_sentiment_score": 0.173706, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.877135", "ticker_sentiment_score": "0.298225", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2024/04/24/evogene-nasdaqevgn-coverage-initiated-at-stocknews-com-2.html", "time_published": "20240424T063847", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com initiated coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a report issued on Wednesday. The brokerage set a \"sell\" rating on the biotechnology company's stock. Evogene stock opened at $0.66 on Wednesday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Earnings", "relevance_score": "0.857896"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.14973, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.881404", "ticker_sentiment_score": "0.259417", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.137671", "ticker_sentiment_score": "0.140379", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2024/04/16/evogene-nasdaqevgn-coverage-initiated-at-stocknews-com.html", "time_published": "20240416T061450", "authors": ["Defense World Staff"], "summary": "Analysts at StockNews.com began coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a research note issued to investors on Tuesday. The firm set a \"sell\" rating on the biotechnology company's stock. Evogene stock opened at $0.69 on Tuesday.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo-1200x675.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.232335, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.825924", "ticker_sentiment_score": "0.385325", "ticker_sentiment_label": "Bullish"}, {"ticker": "SCHW", "relevance_score": "0.077343", "ticker_sentiment_score": "0.112912", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.077343", "ticker_sentiment_score": "0.112912", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.153961", "ticker_sentiment_score": "0.223428", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WMT", "relevance_score": "0.077343", "ticker_sentiment_score": "0.112912", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fungicides Market Size is projected to reach USD 23,393.85 million by 2031, growing at a CAGR of 4.6%: Straits Research", "url": "https://www.benzinga.com/pressreleases/24/03/g37987844/fungicides-market-size-is-projected-to-reach-usd-23-393-85-million-by-2031-growing-at-a-cagr-of-4-", "time_published": "20240328T155500", "authors": ["Globe Newswire"], "summary": "New York, United States, March 28, 2024 ( GLOBE NEWSWIRE ) -- Modern crop protection against fungal diseases must include fungicides. Due to changes in farming practices and technological advancements, farmers are now encouraged to practice effective pest management.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.163042, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "META", "relevance_score": "0.037213", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.074345", "ticker_sentiment_score": "0.093147", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAYZF", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.061172", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVO", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.061172", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.061172", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.037213", "ticker_sentiment_score": "0.196528", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NUFMF", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.061172", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOMMF", "relevance_score": "0.037213", "ticker_sentiment_score": "-0.061172", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification", "url": "https://www.prnewswire.com/il/news-releases/evogene-reports-receipt-of-nasdaq-minimum-bid-price-notification-302094390.html", "time_published": "20240320T130000", "authors": ["Evogene"], "summary": "REHOVOT, Israel, March 20, 2024 /PRNewswire/ -- Evogene Ltd. ( Nasdaq: EVGN, TASE: EVGN ) ( the \"Company\", \"Evogene\" ) , a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, today reported that the ...", "banner_image": "https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.94762"}], "overall_sentiment_score": 0.155157, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.640133", "ticker_sentiment_score": "0.273797", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party' - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/24/03/37535196/israeli-company-reports-record-2023-revenue-wants-to-transition-cannabis-operations-to-third-par", "time_published": "20240307T142011", "authors": ["Jelena Martinovic"], "summary": "Evogene Ltd. EVGN EVGN announced on Thursday its financial results for the fourth quarter and full-year period ending December 31, 2023. In the fourth quarter revenues amounted to $578 000, down 12% year-over-year.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/pepi-stojanovski-MJSFNZ8BAXw-unsplash.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.744043"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.144978, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.442339", "ticker_sentiment_score": "0.106911", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.077845", "ticker_sentiment_score": "0.005146", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( EVGN )  Reports Q4 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2237240/evogene-evgn-reports-q4-loss-misses-revenue-estimates", "time_published": "20240307T142003", "authors": ["Zacks Equity Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of 7.14% and 66.59%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default265.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.119338, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.40348", "ticker_sentiment_score": "0.106851", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.208764", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mirum Pharmaceuticals, Inc.  ( MIRM )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2233406/mirum-pharmaceuticals-inc-mirm-reports-q4-loss-tops-revenue-estimates", "time_published": "20240228T223504", "authors": ["Zacks Equity Research"], "summary": "Mirum Pharmaceuticals, Inc. (MIRM) delivered earnings and revenue surprises of -94.12% and 4.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default65.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.119093, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137278", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIRM", "relevance_score": "0.396052", "ticker_sentiment_score": "0.099584", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fate Therapeutics  ( FATE )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2231983/fate-therapeutics-fate-reports-q4-loss-tops-revenue-estimates", "time_published": "20240226T221004", "authors": ["Zacks Equity Research"], "summary": "Fate Therapeutics (FATE) delivered earnings and revenue surprises of 21.05% and 97.18%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default243.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.130712, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.138464", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATE", "relevance_score": "0.399204", "ticker_sentiment_score": "0.135091", "ticker_sentiment_label": "Neutral"}]}, {"title": "AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/agplenus-announces-licensing--collaboration-agreement-with-bayer-to-develop-a-new-sustainable-weed-control-solution-302067303.html", "time_published": "20240221T120000", "authors": [], "summary": "AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.30573, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.508966", "ticker_sentiment_score": "0.324263", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BAYZF", "relevance_score": "0.034332", "ticker_sentiment_score": "0.19783", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/pressreleases/24/02/n37208339/syngenta-and-lavie-bio-announce-partnership-to-discover-and-develop-novel-bio-insecticide", "time_published": "20240220T120000", "authors": ["PRNewswire"], "summary": "Agreement reinforces both companies' commitment to developing and bringing innovative biological solutions to farmers BASEL, Switzerland and REHOVOT, Israel, Feb. 20, 2024 /PRNewswire/ -- Syngenta Crop Protection, a leader in agricultural innovation, and Lavie Bio Ltd., a leading ag-biologicals ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.197073, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.403813", "ticker_sentiment_score": "0.223884", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/pressreleases/24/02/n36951835/evogene-and-verb-biotics-enter-collaboration-agreement-to-advance-probiotic-innovation", "time_published": "20240206T120800", "authors": ["PRNewswire"], "summary": "The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human health and vitality BOSTON and REHOVOT, Israel, Feb. 6, 2024 /PRNewswire/ -- Evogene Ltd.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.330212, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.484191", "ticker_sentiment_score": "0.402326", "ticker_sentiment_label": "Bullish"}]}, {"title": "Agricultural Biotechnology Market Projected to Reach USD 64.7 billion, with Advancing CAGR of 9.5% by 2031: Transparency Market Research, Inc.", "url": "https://www.benzinga.com/pressreleases/24/01/g36696108/agricultural-biotechnology-market-projected-to-reach-usd-64-7-billion-with-advancing-cagr-of-9-5-b", "time_published": "20240119T150000", "authors": ["Globe Newswire"], "summary": "Wilmington, Delaware, United States, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global agricultural biotechnology market is estimated to flourish at a CAGR of 9.5% from 2022 to 2031.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.386661, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.03642", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNKZF", "relevance_score": "0.03642", "ticker_sentiment_score": "0.258925", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTVA", "relevance_score": "0.072765", "ticker_sentiment_score": "0.164699", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GBCMY", "relevance_score": "0.03642", "ticker_sentiment_score": "0.139787", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRGNF", "relevance_score": "0.03642", "ticker_sentiment_score": "-0.079316", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.072765", "ticker_sentiment_score": "0.359923", "ticker_sentiment_label": "Bullish"}, {"ticker": "WMGTF", "relevance_score": "0.108958", "ticker_sentiment_score": "0.12775", "ticker_sentiment_label": "Neutral"}]}, {"title": "StockNews.com Initiates Coverage on Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.defenseworld.net/2024/01/13/stocknews-com-initiates-coverage-on-evogene-nasdaqevgn.html", "time_published": "20240113T065841", "authors": ["Defense World Staff"], "summary": "Investment analysts at StockNews.com assumed coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a report released on Thursday. The firm set a \"sell\" rating on the biotechnology company's stock. Separately, Alliance Global Partners initiated coverage on Evogene in a research note ...", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.216376, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.841282", "ticker_sentiment_score": "0.362851", "ticker_sentiment_label": "Bullish"}, {"ticker": "GLP", "relevance_score": "0.080188", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGGF", "relevance_score": "0.080188", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.159569", "ticker_sentiment_score": "0.220491", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why Evogene  ( EVGN )  is a Great Momentum Stock to Buy", "url": "https://www.zacks.com/stock/news/2209669/heres-why-evogene-evgn-is-a-great-momentum-stock-to-buy", "time_published": "20240112T170004", "authors": ["Zacks Equity Research"], "summary": "Does Evogene (EVGN) have what it takes to be a top stock pick for momentum investors? Let's find out.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default324.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.451494"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.289616, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.57877", "ticker_sentiment_score": "0.351592", "ticker_sentiment_label": "Bullish"}]}, {"title": "Agricultural Biotechnology Market Growth CAGR 8.5% During 2023-2032 | Xcellent Insights", "url": "https://www.benzinga.com/pressreleases/24/01/g36588349/agricultural-biotechnology-market-growth-cagr-8-5-during-2023-2032-xcellent-insights", "time_published": "20240111T060000", "authors": ["Globe Newswire"], "summary": "Pune, Jan. 11, 2024 ( GLOBE NEWSWIRE ) -- The global agricultural biotechnology market size was USD 101.44 billion in 2022 and is expected to register a rapid CAGR of 8.5% during the forecast period.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.684621"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.338545, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.056011", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNKZF", "relevance_score": "0.056011", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.056011", "ticker_sentiment_score": "0.047906", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIHF", "relevance_score": "0.056011", "ticker_sentiment_score": "0.074891", "ticker_sentiment_label": "Neutral"}]}, {"title": "Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/human-microbiome-therapeutics-market-size-to-grow-by-usd-732-95-million-from-2022-to-2027--north-america-to-account-for-41-of-market-growth---technavio-302027860.html", "time_published": "20240108T091500", "authors": [], "summary": "Human Microbiome Therapeutics Market size to grow by USD 732.95 million from 2022 to 2027, North America to ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.243034, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "MCRB", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTC", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNJ", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYBX", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.050679", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Microbial Agricultural Inoculants Market to increase by USD 243.73 million between 2023 to 2028, AquaBella Organic ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/microbial-agricultural-inoculants-market-to-increase-by-usd-243-73-million-between-2023-to-2028--aquabella-organic-solutions-llc-basf-se-bayer-ag-and-more-among-key-companies---technavio-302009337.html", "time_published": "20231208T201500", "authors": [], "summary": "Microbial Agricultural Inoculants Market to increase by USD 243.73 million between 2023 to 2028, AquaBella Organic ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.236565, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.068896", "ticker_sentiment_score": "0.060487", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.068896", "ticker_sentiment_score": "0.060487", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.068896", "ticker_sentiment_score": "0.060487", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAYZF", "relevance_score": "0.068896", "ticker_sentiment_score": "0.060487", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOX", "relevance_score": "0.068896", "ticker_sentiment_score": "0.060487", "ticker_sentiment_label": "Neutral"}]}, {"title": "Agricultural Biologicals Market size to grow by USD 10.45 billion from 2022 to 2027, Agrinos AS, Andermatt Group AG ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/agricultural-biologicals-market-size-to-grow-by-usd-10-45-billion-from-2022-to-2027--agrinos-as-andermatt-group-ag-basf-se-and-more-among-the-key-companies-in-the-market---technavio-302006423.html", "time_published": "20231205T221500", "authors": [], "summary": "Agricultural Biologicals Market size to grow by USD 10.45 billion from 2022 to 2027, Agrinos AS, Andermatt Group AG ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.235602, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.109956", "ticker_sentiment_score": "0.10003", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.109956", "ticker_sentiment_score": "0.10003", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.109956", "ticker_sentiment_score": "0.10003", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAYZF", "relevance_score": "0.109956", "ticker_sentiment_score": "0.10003", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:UZS", "relevance_score": "0.109956", "ticker_sentiment_score": "0.10003", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Compugen  ( CGEN )  Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/2193578/is-compugen-cgen-outperforming-other-medical-stocks-this-year", "time_published": "20231205T144009", "authors": ["Zacks Equity Research"], "summary": "Here is how Compugen (CGEN) and Evogene (EVGN) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default345.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.216029, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.43789", "ticker_sentiment_score": "0.147159", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.807885", "ticker_sentiment_score": "0.340667", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos\u2122 - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/pressreleases/23/12/n36087854/lavie-bio-announces-a-distribution-agreement-with-winfield-united-canada-for-its-bio-inoculant-see", "time_published": "20231205T120000", "authors": ["PRNewswire"], "summary": "The agreement supports Lavie Bio's 2024 sales growth plan for spring wheat, durum, and barley in Canada REHOVOT, Israel, Dec. 5, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.360489, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.421485", "ticker_sentiment_score": "0.229607", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Bears are Losing Control Over Evogene  ( EVGN ) , Here's Why It's a 'Buy' Now", "url": "https://www.zacks.com/stock/news/2190911/bears-are-losing-control-over-evogene-evgn-heres-why-its-a-buy-now", "time_published": "20231129T145502", "authors": ["Zacks Equity Research"], "summary": "After losing some value lately, a hammer chart pattern has been formed for Evogene (EVGN), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default186.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.214041, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.414559", "ticker_sentiment_score": "0.405734", "ticker_sentiment_label": "Bullish"}]}, {"title": "Agricultural Biologicals Market size to increase by USD 10.45 billion from 2022 to 2027- Technavio - PR Newswire", "url": "https://www.prnewswire.com/news-releases/agricultural-biologicals-market-size-to-increase-by-usd-10-45-billion-from-2022-to-2027--technavio-301976709.html", "time_published": "20231103T231800", "authors": [], "summary": "Agricultural Biologicals Market size to increase by USD 10.45 billion from 2022 to 2027- Technavio PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.223985, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.07157", "ticker_sentiment_score": "0.018076", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.07157", "ticker_sentiment_score": "0.018076", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.07157", "ticker_sentiment_score": "0.018076", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAYZF", "relevance_score": "0.07157", "ticker_sentiment_score": "0.018076", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:UZS", "relevance_score": "0.07157", "ticker_sentiment_score": "0.018076", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Stock Rating Upgraded by StockNews.com", "url": "https://www.defenseworld.net/2023/10/28/evogene-nasdaqevgn-stock-rating-upgraded-by-stocknews-com-2.html", "time_published": "20231028T065842", "authors": ["Defense World Staff"], "summary": "Evogene ( NASDAQ:EVGN ) Stock Rating Upgraded by StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}, {"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.236326, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.848095", "ticker_sentiment_score": "0.395131", "ticker_sentiment_label": "Bullish"}, {"ticker": "GLP", "relevance_score": "0.071357", "ticker_sentiment_score": "0.075386", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGGF", "relevance_score": "0.071357", "ticker_sentiment_score": "0.075386", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.142144", "ticker_sentiment_score": "0.224528", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VIRT", "relevance_score": "0.071357", "ticker_sentiment_score": "0.183342", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Stock Rating Upgraded by StockNews.com", "url": "https://www.defenseworld.net/2023/10/03/evogene-nasdaqevgn-stock-rating-upgraded-by-stocknews-com.html", "time_published": "20231003T081846", "authors": ["Defense World Staff"], "summary": "Evogene ( NASDAQ:EVGN ) Stock Rating Upgraded by StockNews ... Defense World ...", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.928769"}], "overall_sentiment_score": 0.231976, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.070725", "ticker_sentiment_score": "0.104793", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCO", "relevance_score": "0.070725", "ticker_sentiment_score": "0.104793", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.140896", "ticker_sentiment_score": "0.212174", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EVGN", "relevance_score": "0.889875", "ticker_sentiment_score": "0.394104", "ticker_sentiment_label": "Bullish"}, {"ticker": "GLP", "relevance_score": "0.070725", "ticker_sentiment_score": "0.028104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGGF", "relevance_score": "0.070725", "ticker_sentiment_score": "0.028104", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.070725", "ticker_sentiment_score": "0.104793", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.070725", "ticker_sentiment_score": "0.172553", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Upgraded to Sell at StockNews.com", "url": "https://www.defenseworld.net/2023/10/03/evogene-nasdaqevgn-upgraded-to-sell-at-stocknews-com.html", "time_published": "20231003T081841", "authors": ["Defense World Staff"], "summary": "StockNews.com upgraded shares of Evogene ( NASDAQ:EVGN - Free Report ) to a sell rating in a research report report published on Monday morning.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.225586, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.071784", "ticker_sentiment_score": "0.044522", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCO", "relevance_score": "0.071784", "ticker_sentiment_score": "0.044522", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.91305", "ticker_sentiment_score": "0.386718", "ticker_sentiment_label": "Bullish"}, {"ticker": "GLP", "relevance_score": "0.071784", "ticker_sentiment_score": "0.101615", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGGF", "relevance_score": "0.071784", "ticker_sentiment_score": "0.101615", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.071784", "ticker_sentiment_score": "0.044522", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRT", "relevance_score": "0.071784", "ticker_sentiment_score": "0.176618", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Casterra Delivers First Shipment of Castor Seeds to Africa - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/pressreleases/23/09/n34943045/casterra-delivers-first-shipment-of-castor-seeds-to-africa", "time_published": "20230927T110000", "authors": ["PRNewswire"], "summary": "This first shipment, valued at approximately US$1 million, is part of a framework agreement with a world-leading oil and gas company", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.305861, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.613172", "ticker_sentiment_score": "0.318894", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Evogene Shares Are Moving - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/news/23/09/34796022/why-evogene-shares-are-moving", "time_published": "20230921T152428", "authors": ["Henry Khederian"], "summary": "Evogene Ltd EVGN shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the minimum bid price rule.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/21/chart-1905225.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.036007, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.95919", "ticker_sentiment_score": "0.06898", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( EVGN )  Could Find a Support Soon, Here's Why You Should Buy the Stock Now", "url": "https://www.zacks.com/stock/news/2138676/evogene-evgn-could-find-a-support-soon-heres-why-you-should-buy-the-stock-now", "time_published": "20230821T135507", "authors": ["Zacks Equity Research"], "summary": "Evogene (EVGN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default247.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}], "overall_sentiment_score": 0.17327, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.423843", "ticker_sentiment_score": "0.376453", "ticker_sentiment_label": "Bullish"}]}, {"title": "Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/23/08/33894969/israeli-cannabis-co-reports-solid-q2-performance-nearing-growth-targets", "time_published": "20230817T133728", "authors": ["Jelena Martinovic"], "summary": "Cannabis company Evogene Ltd. EVGN EVGN announced its second quarter financial results on Thursday for the period ended June 30, 2023, revealing a significant year-over-year uptick in revenue to roughly $654 000 compared to approximately $312 000 in the same period the previous year.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/08/17/cannabis_debt_nikolayfrolochkin_and_ganjaspliffstoreuk_by_pixabay13.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.312341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.26042", "ticker_sentiment_score": "0.17317", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IMCC", "relevance_score": "0.06623", "ticker_sentiment_score": "0.100352", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.06623", "ticker_sentiment_score": "0.263054", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( EVGN )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2137362/evogene-evgn-reports-q2-loss-lags-revenue-estimates", "time_published": "20230817T121511", "authors": ["Zacks Equity Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of 10.53% and 15.07%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default81.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.135654, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.407844", "ticker_sentiment_score": "0.146019", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVTX", "relevance_score": "0.211191", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "TScan Therapeutics, Inc.  ( TCRX )  Reports Q2 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2134846/tscan-therapeutics-inc-tcrx-reports-q2-loss-misses-revenue-estimates", "time_published": "20230810T122509", "authors": ["Zacks Equity Research"], "summary": "TScan Therapeutics, Inc. (TCRX) delivered earnings and revenue surprises of 32.89% and 16.05%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default339.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.121636, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.136499", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRX", "relevance_score": "0.393977", "ticker_sentiment_score": "0.107754", "ticker_sentiment_label": "Neutral"}]}, {"title": "Mersana Therapeutics, Inc.  ( MRSN )  Reports Q2 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2133638/mersana-therapeutics-inc-mrsn-reports-q2-loss-misses-revenue-estimates", "time_published": "20230808T134005", "authors": ["Zacks Equity Research"], "summary": "Mersana Therapeutics, Inc. (MRSN) delivered earnings and revenue surprises of -20.51% and 54.73%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default137.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.100862, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.136888", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.395012", "ticker_sentiment_score": "0.043456", "ticker_sentiment_label": "Neutral"}]}, {"title": "CRISPR Therapeutics AG  ( CRSP )  Reports Q2 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2133298/crispr-therapeutics-ag-crsp-reports-q2-loss-tops-revenue-estimates", "time_published": "20230807T211506", "authors": ["Zacks Equity Research"], "summary": "CRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 55.05% and 2,085.45%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default309.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.128373, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.136499", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSP", "relevance_score": "0.393977", "ticker_sentiment_score": "0.133835", "ticker_sentiment_label": "Neutral"}]}, {"title": "Agricultural Biologicals Market size to grow by USD 10,457.38 million from 2022 to 2027|Increasing governmental ... - PR Newswire", "url": "https://www.prnewswire.com/news-releases/agricultural-biologicals-market-size-to-grow-by-usd-10-457-38-million-from-2022-to-2027increasing-governmental-support-for-the-use-of-bio-based-products-in-agriculture-will-drive-the-market---technavio-301892883.html", "time_published": "20230805T041500", "authors": [], "summary": "Agricultural Biologicals Market size to grow by USD 10,457.38 million from 2022 to 2027|Increasing governmental ... PR ...", "banner_image": null, "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.198276, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.05133", "ticker_sentiment_score": "0.08848", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.05133", "ticker_sentiment_score": "0.08848", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVZMY", "relevance_score": "0.102449", "ticker_sentiment_score": "0.050235", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAYZF", "relevance_score": "0.05133", "ticker_sentiment_score": "0.08848", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:UZS", "relevance_score": "0.05133", "ticker_sentiment_score": "0.08848", "ticker_sentiment_label": "Neutral"}]}, {"title": "Cidara Therapeutics  ( CDTX )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2132246/cidara-therapeutics-cdtx-reports-q2-loss-lags-revenue-estimates", "time_published": "20230803T212518", "authors": ["Zacks Equity Research"], "summary": "Cidara Therapeutics (CDTX) delivered earnings and revenue surprises of -75% and 46.90%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default170.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999953"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.146589, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.138066", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDTX", "relevance_score": "0.398148", "ticker_sentiment_score": "0.105853", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  Coverage Initiated at StockNews.com", "url": "https://www.defenseworld.net/2023/08/02/evogene-nasdaqevgn-coverage-initiated-at-stocknews-com.html", "time_published": "20230802T085514", "authors": ["Defense World Staff"], "summary": "Stock analysts at StockNews.com assumed coverage on shares of Evogene ( NASDAQ:EVGN - Get Free Report ) in a research report issued on Monday. The firm set a \"sell\" rating on the biotechnology company's stock. Other analysts have also issued reports about the stock.", "banner_image": "https://www.marketbeat.com/logos/evogene-ltd-logo.jpg?v=20230112064238", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "www.defenseworld.net", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}], "overall_sentiment_score": 0.259411, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.179788", "ticker_sentiment_score": "0.271518", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EVGN", "relevance_score": "0.827318", "ticker_sentiment_score": "0.42785", "ticker_sentiment_label": "Bullish"}, {"ticker": "VIRT", "relevance_score": "0.090474", "ticker_sentiment_score": "0.197589", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Evogene Stock Is Tanking Today - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/23/07/33250989/why-evogene-stock-is-tanking-today", "time_published": "20230717T142845", "authors": ["Vuk Zdinjak"], "summary": "Evogene Ltd. EVGN EVGN shares were trading 20% lower at $1.12 per share at the time of writing Monday morning.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/17/cannabis_stocks_going_down_stefan_balaz_by_shutterstock_and_peter_pike_by_pixabay.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.457304, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.439786", "ticker_sentiment_score": "0.230822", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SSTK", "relevance_score": "0.115787", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLP", "relevance_score": "0.115787", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGGF", "relevance_score": "0.115787", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALMFF", "relevance_score": "0.115787", "ticker_sentiment_score": "0.168996", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene Announces Pricing of US$8,500,000 Registered Direct Offering", "url": "https://www.prnewswire.com/news-releases/evogene-announces-pricing-of-us8-500-000-registered-direct-offering-301878380.html", "time_published": "20230717T121500", "authors": ["Evogene"], "summary": "Evogene Announces Pricing of US$8500000 Registered Direct Offering USA - English PR ...", "banner_image": "https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Retail & Wholesale", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.247139, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.648684", "ticker_sentiment_score": "0.359859", "ticker_sentiment_label": "Bullish"}, {"ticker": "GLP", "relevance_score": "0.092748", "ticker_sentiment_score": "0.157882", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALGGF", "relevance_score": "0.092748", "ticker_sentiment_score": "0.157882", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALMFF", "relevance_score": "0.046452", "ticker_sentiment_score": "0.162386", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience", "url": "https://www.prnewswire.com/news-releases/lavie-bio-announces-licensing-agreement-for-bio-fungicides-with-corteva-agriscience-301878374.html", "time_published": "20230717T113000", "authors": ["Lavie Bio"], "summary": "Corteva to receive exclusive rights to further develop and commercialize Lavie Bio's lead product candidates for fruit rot and powdery mildew fungicide biologicals", "banner_image": "https://mma.prnewswire.com/media/1947468/Evogene.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.424206, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.699089", "ticker_sentiment_score": "0.711212", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTVA", "relevance_score": "0.832201", "ticker_sentiment_score": "0.650824", "ticker_sentiment_label": "Bullish"}]}, {"title": "Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Aehr Test Systems  ( NASDAQ:AEHR ) , ACADIA Pharmaceuticals  ( NASDAQ:ACAD ) ", "url": "https://www.benzinga.com/news/23/07/33230027/why-aehr-test-systems-shares-are-trading-higher-here-are-20-stocks-moving-premarket", "time_published": "20230714T121649", "authors": ["Lisa Levin"], "summary": "Ainos, Inc. AIMD shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday. Intuitive Machines, Inc. LUNR shares gained 29.1% to $11.02 in pre-market trading. Intuitive Machines is closing in on delivering its Nova-C lunar lander to Florida for launch.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/14/image9.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.967645"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.110743, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AIMD", "relevance_score": "0.131284", "ticker_sentiment_score": "0.311535", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JZXN", "relevance_score": "0.131284", "ticker_sentiment_score": "-0.051722", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAOP", "relevance_score": "0.131284", "ticker_sentiment_score": "-0.107321", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOK", "relevance_score": "0.131284", "ticker_sentiment_score": "0.049954", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMMLD", "relevance_score": "0.065866", "ticker_sentiment_score": "0.016207", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNR", "relevance_score": "0.195814", "ticker_sentiment_score": "0.257778", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARBB", "relevance_score": "0.131284", "ticker_sentiment_score": "0.184975", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AEHR", "relevance_score": "0.131284", "ticker_sentiment_score": "0.219075", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LESL", "relevance_score": "0.195814", "ticker_sentiment_score": "0.07934", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.131284", "ticker_sentiment_score": "0.286722", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EVGN", "relevance_score": "0.131284", "ticker_sentiment_score": "-0.015524", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTBP", "relevance_score": "0.131284", "ticker_sentiment_score": "0.441941", "ticker_sentiment_label": "Bullish"}, {"ticker": "ACAD", "relevance_score": "0.195814", "ticker_sentiment_score": "-0.163665", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "THRX", "relevance_score": "0.131284", "ticker_sentiment_score": "-0.11088", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDS", "relevance_score": "0.131284", "ticker_sentiment_score": "-0.055925", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/equities/23/07/33097220/evogenes-casterra-gets-2-2m-orders-to-supply-castor-seeds", "time_published": "20230703T160718", "authors": ["Nabaparna Bhattacharya"], "summary": "Evogene Ltd. EVGN said its unit Casterra Ag Ltd. has bagged additional purchase orders worth $2.2 million to supply castor seeds for new African territories for biofuel production. Casterra's castor seeds, developed with Evogene's GeneRator AI Tech Engine, will be used to grow Castor to produce ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/07/03/evgn.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.466744, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.570165", "ticker_sentiment_score": "0.518606", "ticker_sentiment_label": "Bullish"}]}, {"title": "Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories", "url": "https://www.prnewswire.com/news-releases/casterra-announces-additional-2-2-million-of-purchase-orders-to-supply-castor-seeds-for-new-african-territories-301868785.html", "time_published": "20230703T110000", "authors": ["Casterra Ag Ltd."], "summary": "The biodiesel market is estimated at ~$92 billion in 2021, which is about 9% of the overall global diesel market and is expected to reach ~$190 billion by 20301. In current industry practice, biodiesel is based on a mix of about 93-95% fossil oil and 5-7% non-fossil oil from plants or other ...", "banner_image": "https://mma.prnewswire.com/media/1947467/Casterra.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.248297, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.388879", "ticker_sentiment_score": "0.187572", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Evogene  ( EVGN )  Stock Is Trading Higher - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/news/23/06/32946964/why-evogene-evgn-stock-is-trading-higher", "time_published": "20230621T134613", "authors": ["Henry Khederian"], "summary": "Evogene Ltd EVGN shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to sell its castor seeds for sustainable biofuel production, with initial purchase orders of $9.1 million.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/06/21/hd-wallpaper-2836301.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.236343, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.866386", "ticker_sentiment_score": "0.536542", "ticker_sentiment_label": "Bullish"}]}, {"title": "This Week in Environment News: 10 Stories You Need to See", "url": "https://www.prnewswire.com/news-releases/this-week-in-environment-news-10-stories-you-need-to-see-301829146.html", "time_published": "20230519T110200", "authors": ["PR Newswire"], "summary": "A roundup of the week's most newsworthy environment industry press releases from PR Newswire, including The Weather Company's staying power and a new AI-powered hummingbird feeder. NEW YORK, May 19, 2023 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to ...", "banner_image": "https://mma.prnewswire.com/media/1885554/cision_PRNewswire_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.260492, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.03443", "ticker_sentiment_score": "0.103771", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.03443", "ticker_sentiment_score": "-0.051722", "ticker_sentiment_label": "Neutral"}, {"ticker": "FE", "relevance_score": "0.068797", "ticker_sentiment_score": "0.285909", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( EVGN )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2096710/evogene-evgn-reports-q1-loss-misses-revenue-estimates", "time_published": "20230518T121505", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of 6.25% and 26.32%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default188.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.103233, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.404563", "ticker_sentiment_score": "0.044202", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFCR", "relevance_score": "0.140485", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Q1 Revenue Grows 170% YoY, Here Are The Details - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/23/05/32463463/evogene-q1-revenue-grows-170-yoy-here-are-the-details", "time_published": "20230518T120207", "authors": ["Vuk Zdinjak"], "summary": "Evogene Ltd. EVGN EVGN released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in the same period the previous year.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/18/giorgio.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.466188, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.310843", "ticker_sentiment_score": "0.250454", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTVA", "relevance_score": "0.10607", "ticker_sentiment_score": "0.124506", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene: Q1 Earnings Snapshot", "url": "https://apnews.com/article/earnings-3b1fe1baae639f651b28e6f4c242cee6", "time_published": "20230518T110820", "authors": [], "summary": "REHOVOT, Israel ( AP ) - REHOVOT, Israel ( AP ) - Evogene Ltd. ( EVGN ) on Thursday reported a loss of $6.3 million in its first quarter. The Rehovot, Israel-based company said it had a loss of 15 cents per share. The agricultural company posted revenue of $641,000 in the period.", "banner_image": "https://storage.googleapis.com/afs-prod/media/afs:Medium:751921853724/700.png", "source": "Associated Press", "category_within_source": "Business", "source_domain": "apnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.077426, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.993614", "ticker_sentiment_score": "-0.213749", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Ikena Oncology, Inc.  ( IKNA )  Reports Q1 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2095199/ikena-oncology-inc-ikna-reports-q1-loss-tops-revenue-estimates", "time_published": "20230515T130504", "authors": ["Zacks Investment Research"], "summary": "Ikena Oncology, Inc. (IKNA) delivered earnings and revenue surprises of 15.22% and 8.21%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default346.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.151554, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137671", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IKNA", "relevance_score": "0.397098", "ticker_sentiment_score": "0.203436", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Telesis Bio  ( TBIO )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2094422/telesis-bio-tbio-reports-q1-loss-misses-revenue-estimates", "time_published": "20230511T212514", "authors": ["Zacks Investment Research"], "summary": "Telesis Bio (TBIO) delivered earnings and revenue surprises of 2.63% and 14.65%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default126.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.14027, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.138863", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBIO", "relevance_score": "0.400265", "ticker_sentiment_score": "0.178964", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "BioCardia, Inc.  ( BCDA )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2093795/biocardia-inc-bcda-reports-q1-loss-misses-revenue-estimates", "time_published": "20230510T214513", "authors": ["Zacks Investment Research"], "summary": "BioCardia, Inc. (BCDA) delivered earnings and revenue surprises of -30.77% and 81.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default44.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.124242, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.139669", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCDA", "relevance_score": "0.402403", "ticker_sentiment_score": "0.118134", "ticker_sentiment_label": "Neutral"}]}, {"title": "Avidity Biosciences, Inc.  ( RNA )  Reports Q1 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2092806/avidity-biosciences-inc-rna-reports-q1-loss-tops-revenue-estimates", "time_published": "20230509T221516", "authors": ["Zacks Investment Research"], "summary": "Avidity Biosciences, Inc. (RNA) delivered earnings and revenue surprises of 17.78% and 7.15%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default133.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.110024, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137278", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.396052", "ticker_sentiment_score": "0.070403", "ticker_sentiment_label": "Neutral"}]}, {"title": "LOCL: Don't Sow Your Oats With These Failing Stocks", "url": "https://stocknews.com/news/locl-evgn-edbl-dont-sow-your-oats-with-these-failing-stocks/", "time_published": "20230330T161605", "authors": [], "summary": "High inflation is increasing the cost of inputs like seeds, fertilizers, and machinery, making it more expensive for farmers to produce their crops. Moreover, labor scarcity is becoming a growing concern in the agriculture industry, with many farmers struggling to find enough workers to meet the ...", "banner_image": "https://stocknews.com/wp-content/uploads/2022/06/shutterstock_1481652227-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Earnings", "relevance_score": "0.999862"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.062724, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.235442", "ticker_sentiment_score": "0.065825", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDBL", "relevance_score": "0.197091", "ticker_sentiment_score": "0.217867", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LOCL", "relevance_score": "0.235442", "ticker_sentiment_score": "0.209647", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene 2022 Revenue Grows 80% To 1.7M - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/23/03/31279175/evogene-2022-revenue-grows-80-to-1-7m", "time_published": "20230309T151819", "authors": ["Vuk Zdinjak"], "summary": "Evogene Ltd. EVGN EVGN 2022 revenue was $1.7 million, an increase of 80% compared to $930,000 in 2021. Revenues for the fourth quarter of 2022 were $660,000, an increase of 112% compared to $311,000 in the same period the previous year. Gross profit was $296,000 compared to $44,000 in the same ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/09/esteban2.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.168282, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.339745", "ticker_sentiment_score": "0.482844", "ticker_sentiment_label": "Bullish"}]}, {"title": "Evogene  ( EVGN )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2063474/evogene-evgn-reports-q4-loss-tops-revenue-estimates", "time_published": "20230309T134506", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of 66.67% and 20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default175.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.119115, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.406745", "ticker_sentiment_score": "0.098752", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBIO", "relevance_score": "0.14131", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Guardant Health  ( GH )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2058371/guardant-health-gh-reports-q4-loss-tops-revenue-estimates", "time_published": "20230223T222512", "authors": ["Zacks Investment Research"], "summary": "Guardant Health (GH) delivered earnings and revenue surprises of 2.86% and 1.17%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default136.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.119114, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.139669", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.402403", "ticker_sentiment_score": "0.098007", "ticker_sentiment_label": "Neutral"}]}, {"title": "Canonic Launches Six Second-Generation Cannabis Products With Higher THC And Rich Terpene Profiles - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/23/02/30990773/canonic-launches-six-second-generation-cannabis-products-with-higher-thc-and-rich-terpene-profil", "time_published": "20230221T160840", "authors": ["Vuk Zdinjak"], "summary": "Canonic Ltd., a wholly owned subsidiary of Evogene Ltd. EVGN EVGN launched six second-generation hybrid cannabis products in Israel. The design and development of these new cannabis products leveraged Evogene's GeneRator AI tech-engine to select desirable characteristics such as THC content and ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/02/21/canonic.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.215024, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.38489", "ticker_sentiment_score": "0.319143", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Casterra Announces Agreement with World Leading Energy Company to Cultivate its Castor Varieties at Commercial Scale", "url": "https://www.benzinga.com/pressreleases/23/01/n30479260/casterra-announces-agreement-with-world-leading-energy-company-to-cultivate-its-castor-varieties-a", "time_published": "20230119T120000", "authors": ["PRNewswire"], "summary": "REHOVOT, Israel, Jan. 19, 2023 /PRNewswire/ -- Casterra Ag Ltd. ( \"Casterra\" ) , the integrated castor cultivation solution company and a subsidiary of Evogene Ltd. ( \"Evogene\" ) EVGN EVGN, announced today that it has entered into an agreement with one of the world's leading energy companies, ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.302747, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.436009", "ticker_sentiment_score": "0.310304", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "All You Need to Know About Evogene  ( EVGN )  Rating Upgrade to Strong Buy", "url": "https://www.zacks.com/stock/news/2040895/all-you-need-to-know-about-evogene-evgn-rating-upgrade-to-strong-buy", "time_published": "20230118T170005", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default45.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.318177, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.366061", "ticker_sentiment_score": "0.356251", "ticker_sentiment_label": "Bullish"}]}, {"title": "Evogene to Receive $3.5 million Payment Related to Patent Portfolio under its Existing Seed Traits Collaboration with Bayer - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/pressreleases/22/12/n30003955/evogene-to-receive-3-5-million-payment-related-to-patent-portfolio-under-its-existing-seed-traits-", "time_published": "20221208T120000", "authors": ["PRNewswire"], "summary": "REHOVOT, Israel, Dec. 8, 2022 /PRNewswire/ -- Evogene Ltd. EVGN EVGN ( the \"Company\", \"Evogene\" ) , a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, announced today that Bayer will pay Evogene an ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.215387, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.853391", "ticker_sentiment_score": "0.377905", "ticker_sentiment_label": "Bullish"}]}, {"title": "Evogene  ( EVGN )  Reports Q3 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2019282/evogene-evgn-reports-q3-loss-tops-revenue-estimates", "time_published": "20221117T132504", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of 20% and 79.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default278.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.089265, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CDMO", "relevance_score": "0.211191", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.407844", "ticker_sentiment_score": "-0.00556", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Q3 Revenue Grows 208% YoY, Here Are The Details - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/news/earnings/22/11/29764354/evogene-q3-revenue-grows-208-yoy-here-are-the-details", "time_published": "20221117T125557", "authors": ["Vuk Zdinjak"], "summary": "Evogene Ltd. EVGN EVGN Q3 2022 revenues were $466,000, a 208% increase in comparison to $151,000 in the same period of the previous year and were primarily due to revenues recognized per the collaboration agreement of Evogene's subsidiary AgPlenus with Corteva.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/11/17/evogene.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.276977, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.409503", "ticker_sentiment_score": "0.425681", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTVA", "relevance_score": "0.107016", "ticker_sentiment_score": "0.136892", "ticker_sentiment_label": "Neutral"}]}, {"title": "Roivant Sciences Ltd.  ( ROIV )  Reports Q2 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2017807/roivant-sciences-ltd-roiv-reports-q2-loss-tops-revenue-estimates", "time_published": "20221114T141507", "authors": ["Zacks Investment Research"], "summary": "Roivant Sciences Ltd. (ROIV) delivered earnings and revenue surprises of -2.44% and 86.73%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default213.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.098601, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137278", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.396052", "ticker_sentiment_score": "-0.005446", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wave Life Sciences  ( WVE )  Reports Q3 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/2016682/wave-life-sciences-wve-reports-q3-loss-misses-revenue-estimates", "time_published": "20221110T134508", "authors": ["Zacks Investment Research"], "summary": "Wave Life Sciences (WVE) delivered earnings and revenue surprises of 12.50% and 94.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default286.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.098591, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137278", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.396052", "ticker_sentiment_score": "0.032697", "ticker_sentiment_label": "Neutral"}]}, {"title": "Clearside Biomedical, Inc.  ( CLSD )  Reports Q3 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2016108/clearside-biomedical-inc-clsd-reports-q3-loss-lags-revenue-estimates", "time_published": "20221109T140505", "authors": ["Zacks Investment Research"], "summary": "Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -425% and 98.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default87.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.07295, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.138066", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSD", "relevance_score": "0.398148", "ticker_sentiment_score": "-0.002734", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fulcrum Therapeutics, Inc.  ( FULC )  Reports Q3 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/2015316/fulcrum-therapeutics-inc-fulc-reports-q3-loss-lags-revenue-estimates", "time_published": "20221108T133505", "authors": ["Zacks Investment Research"], "summary": "Fulcrum Therapeutics, Inc. (FULC) delivered earnings and revenue surprises of 19.35% and 45.86%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default81.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.101159, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.138066", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FULC", "relevance_score": "0.398148", "ticker_sentiment_score": "0.041252", "ticker_sentiment_label": "Neutral"}]}, {"title": "PFE: These 3 Stocks Are a Must When Building Your Dividend Portfolio", "url": "https://stocknews.com/news/pfe-icl-arc-these-3-stocks-are-a-must-when-building-your-dividend/", "time_published": "20221028T194501", "authors": [], "summary": "As the Federal Reserve tries to reduce rising prices by hiking interest rates, borrowing and spending have become costlier for businesses and individuals. \"Borrowing costs for homebuyers, car buyers, and credit card borrowers have increased at the fastest pace in decades,\" stated chief financial ...", "banner_image": "https://stocknews.com/wp-content/uploads/2021/12/shutterstock_1274515525-1-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}, {"topic": "Earnings", "relevance_score": "0.999921"}], "overall_sentiment_score": 0.292116, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.111488", "ticker_sentiment_score": "0.279001", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GBT", "relevance_score": "0.111488", "ticker_sentiment_score": "0.189952", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARC", "relevance_score": "0.220809", "ticker_sentiment_score": "0.20654", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICL", "relevance_score": "0.291471", "ticker_sentiment_score": "0.40147", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.325924", "ticker_sentiment_score": "0.206765", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "PFE: 3 Dividend Stocks to Buy That'll Pay You Forever", "url": "https://stocknews.com/news/pfe-icl-karo-3-dividend-stocks-to-buy-thatll-pay-you-forever/", "time_published": "20221018T194108", "authors": [], "summary": "The hotter-than-expected inflation and employment data indicate another aggressive interest rate hike by the Fed in November.", "banner_image": "https://stocknews.com/wp-content/uploads/2021/12/shutterstock_1271080456-1-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.576289"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999967"}, {"topic": "Earnings", "relevance_score": "0.999864"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.209595, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "KARO", "relevance_score": "0.188193", "ticker_sentiment_score": "0.18203", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICL", "relevance_score": "0.296761", "ticker_sentiment_score": "0.41772", "ticker_sentiment_label": "Bullish"}, {"ticker": "MS", "relevance_score": "0.03798", "ticker_sentiment_score": "-0.039819", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.075874", "ticker_sentiment_score": "0.271081", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GBT", "relevance_score": "0.075874", "ticker_sentiment_score": "0.120346", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.366061", "ticker_sentiment_score": "0.197142", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BNTX", "relevance_score": "0.075874", "ticker_sentiment_score": "0.04585", "ticker_sentiment_label": "Neutral"}]}, {"title": "Canonic Launches Its High THC Medical Cannabis Products In Israel - Evogene  ( NASDAQ:EVGN ) ", "url": "https://www.benzinga.com/markets/cannabis/22/09/28951289/canonic-launches-its-high-thc-medical-cannabis-products-in-israel", "time_published": "20220921T153820", "authors": ["Vuk Zdinjak"], "summary": "Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. EVGN EVGN, is launching its second-generation products in Israel. The design of the new products leverages market feedback since Canonic's launch of its first-generation ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/09/21/diyahna-lewis---jxxyiuhnu-unsplash.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.231196, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.529185", "ticker_sentiment_score": "0.371049", "ticker_sentiment_label": "Bullish"}]}, {"title": "Evogene  ( NASDAQ:EVGN )  - Canonic Advances its Penetration into Europe by Signing its First Licensing Agreement with GroVida", "url": "https://www.benzinga.com/pressreleases/22/09/n28844027/canonic-advances-its-penetration-into-europe-by-signing-its-first-licensing-agreement-with-grovida", "time_published": "20220913T110000", "authors": ["PRNewswire"], "summary": "REHOVOT, Israel , Sept. 13, 2022 /PRNewswire/ -- Canonic Ltd., focused on the development of medical grade cannabis products and a wholly owned subsidiary of Evogene Ltd. EVGN EVGN, announced today that it has signed a non-exclusive licensing agreement with leading Portugal-based cannabis ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.215116, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APG", "relevance_score": "0.042496", "ticker_sentiment_score": "0.167098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EVGN", "relevance_score": "0.442222", "ticker_sentiment_score": "0.22935", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": " ( AHI ) ,  ( ALNA )  - Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket", "url": "https://www.benzinga.com/news/22/09/28752577/why-dwac-is-trading-lower-by-around-19-here-are-32-stocks-moving-premarket", "time_published": "20220906T104131", "authors": ["Lisa Levin"], "summary": "First Wave BioPharma, Inc. FWBI shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday. Organovo Holdings, Inc. ONVO rose 25.1% to $2.89 in pre-market trading. Tian Ruixiang Holdings Ltd TIRX shares rose 24% to $0.85 in pre-market trading after declining around 5% on Friday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/09/06/image26.jpeg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.982687"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.055466, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.305198", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRTD", "relevance_score": "0.170878", "ticker_sentiment_score": "0.058934", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHI", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.075069", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.005868", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.151393", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KPRX", "relevance_score": "0.114409", "ticker_sentiment_score": "0.120794", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.114409", "ticker_sentiment_score": "0.186172", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NFE", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIVE", "relevance_score": "0.170878", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBSV", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.005868", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMST", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.207029", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DWAC", "relevance_score": "0.114409", "ticker_sentiment_score": "0.096721", "ticker_sentiment_label": "Neutral"}, {"ticker": "NINE", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.01446", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.305198", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TENX", "relevance_score": "0.057352", "ticker_sentiment_score": "-0.199999", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TIRX", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.048287", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXL", "relevance_score": "0.170878", "ticker_sentiment_score": "0.069589", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCN", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.14803", "ticker_sentiment_label": "Neutral"}, {"ticker": "KUKE", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.306319", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GOGL", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.424357", "ticker_sentiment_label": "Bearish"}, {"ticker": "IDEX", "relevance_score": "0.170878", "ticker_sentiment_score": "-0.00582", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIAF", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.170878", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.114409", "ticker_sentiment_score": "0.310801", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PXMD", "relevance_score": "0.114409", "ticker_sentiment_score": "-0.209757", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUBY", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.057352", "ticker_sentiment_score": "-0.004008", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONVO", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHLR", "relevance_score": "0.114409", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Ltd.  ( EVGN )  - Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know", "url": "https://www.benzinga.com/markets/cannabis/22/08/28704011/evogene-q2-revenue-grows-131-here-is-what-you-need-to-know", "time_published": "20220831T153210", "authors": ["Vuk Zdinjak"], "summary": "Evogene Ltd. EVGN EVGN Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year. Revenues were primarily due to the initial sales of Lavie Bio's Thrivus product ( previously branded as Result ) and sales of Canonic products in the Israeli market.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/08/31/richard.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.173984, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.499102", "ticker_sentiment_score": "0.312117", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Evogene  ( EVGN )  Reports Q2 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/1974398/evogene-evgn-reports-q2-loss-tops-revenue-estimates", "time_published": "20220831T122502", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of -16.67% and 83.53%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default110.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999892"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.119428, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CDMO", "relevance_score": "0.209365", "ticker_sentiment_score": "0.12165", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.404563", "ticker_sentiment_score": "0.0332", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Reports Second Quarter 2022 Financial Results", "url": "https://www.prnewswire.com/news-releases/evogene-reports-second-quarter-2022-financial-results-301615435.html", "time_published": "20220831T110000", "authors": ["Evogene"], "summary": "Conference call and webcast: today, August 31, 2022, 9:00 am ET", "banner_image": "https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Economy - Macro", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.222485, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.471549", "ticker_sentiment_score": "0.3317", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTVA", "relevance_score": "0.022859", "ticker_sentiment_score": "0.168811", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.045699", "ticker_sentiment_score": "0.10642", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Reports Second Quarter 2022 Financial Results", "url": "https://www.prnewswire.com/il/news-releases/evogene-reports-second-quarter-2022-financial-results-301615435.html", "time_published": "20220831T110000", "authors": ["Evogene"], "summary": "Conference call and webcast: today, August 31, 2022, 9:00 am ET", "banner_image": "https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Earnings", "relevance_score": "0.576289"}, {"topic": "Economy - Macro", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.222485, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.471549", "ticker_sentiment_score": "0.3317", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CTVA", "relevance_score": "0.022859", "ticker_sentiment_score": "0.168811", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FOREX:USD", "relevance_score": "0.045699", "ticker_sentiment_score": "0.10642", "ticker_sentiment_label": "Neutral"}]}, {"title": "ICL: 1 ETF and 3 Stocks With Dividend Yields Over 6% Right Now", "url": "https://stocknews.com/news/icl-ewz-arlp-glp-1-etf-and-3-stocks-with-dividend-yields-over-6/", "time_published": "20220830T130912", "authors": [], "summary": "Technical analyst Larry Williams sees the potential for the market to end strong this year. However, after the Federal Reserve's chair Jerome Powell expressed the Fed's commitment to bring down inflation with its rate hikes, experts believe there is still a long way to go before a reversal in ...", "banner_image": "https://stocknews.com/wp-content/uploads/2021/12/shutterstock_1276348102-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.682689"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.999997"}, {"topic": "Earnings", "relevance_score": "0.999174"}, {"topic": "Energy & Transportation", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.201337, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.09186", "ticker_sentiment_score": "0.203815", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLP", "relevance_score": "0.212248", "ticker_sentiment_score": "0.109624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARLP", "relevance_score": "0.241684", "ticker_sentiment_score": "0.214483", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICL", "relevance_score": "0.299478", "ticker_sentiment_score": "0.32922", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VALE", "relevance_score": "0.03068", "ticker_sentiment_score": "0.049998", "ticker_sentiment_label": "Neutral"}]}, {"title": "ICL: 3 Strong Buy Stocks Yielding More Than 9%", "url": "https://stocknews.com/news/icl-sire-educ-3-strong-buy-stocks-yielding-more-than-9/", "time_published": "20220826T123647", "authors": [], "summary": "ICL: 3 Strong Buy Stocks Yielding More Than ...", "banner_image": "https://stocknews.com/wp-content/uploads/2022/06/shutterstock_1581003847-scaled.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Earnings", "relevance_score": "0.990893"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.237004, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.043108", "ticker_sentiment_score": "0.220258", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ICL", "relevance_score": "0.334573", "ticker_sentiment_score": "0.338147", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EDUC", "relevance_score": "0.254307", "ticker_sentiment_score": "0.176928", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SIRE", "relevance_score": "0.29485", "ticker_sentiment_score": "0.159635", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket", "url": "https://www.benzinga.com/news/22/08/28530257/why-hill-international-shares-are-trading-higher-by-58-here-are-25-stocks-moving-premarket", "time_published": "20220817T100654", "authors": ["Lisa Levin"], "summary": "Hill International, Inc. HIL shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share. Vinco Ventures, Inc. BBIG shares rose 31.9% to $1.49 in pre-market trading.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/08/17/image15.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.94309"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.080845, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "A", "relevance_score": "0.04583", "ticker_sentiment_score": "0.212212", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BBIG", "relevance_score": "0.136888", "ticker_sentiment_score": "0.201877", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NBEV", "relevance_score": "0.091509", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRMA", "relevance_score": "0.136888", "ticker_sentiment_score": "0.113997", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCP", "relevance_score": "0.136888", "ticker_sentiment_score": "-0.160901", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAZE", "relevance_score": "0.091509", "ticker_sentiment_score": "0.128069", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.091509", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.091509", "ticker_sentiment_score": "-0.040991", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRZA", "relevance_score": "0.091509", "ticker_sentiment_score": "-0.196281", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ENDP", "relevance_score": "0.091509", "ticker_sentiment_score": "-0.208905", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SAVA", "relevance_score": "0.091509", "ticker_sentiment_score": "0.122835", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNY", "relevance_score": "0.091509", "ticker_sentiment_score": "-0.141686", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMWP", "relevance_score": "0.091509", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBP", "relevance_score": "0.136888", "ticker_sentiment_score": "-0.137963", "ticker_sentiment_label": "Neutral"}, {"ticker": "APWC", "relevance_score": "0.04583", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRC", "relevance_score": "0.136888", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.091509", "ticker_sentiment_score": "0.017202", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIL", "relevance_score": "0.091509", "ticker_sentiment_score": "0.284789", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PIK", "relevance_score": "0.091509", "ticker_sentiment_score": "-0.040991", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.091509", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTL", "relevance_score": "0.136888", "ticker_sentiment_score": "-0.080306", "ticker_sentiment_label": "Neutral"}, {"ticker": "EAR", "relevance_score": "0.136888", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.181819", "ticker_sentiment_score": "0.247451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "REAL", "relevance_score": "0.091509", "ticker_sentiment_score": "-0.17421", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Roivant Sciences Ltd.  ( ROIV )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/1968029/roivant-sciences-ltd-roiv-reports-q1-loss-misses-revenue-estimates", "time_published": "20220815T121505", "authors": ["Zacks Investment Research"], "summary": "Roivant Sciences Ltd. (ROIV) delivered earnings and revenue surprises of -60% and 33.04%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default353.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.103469, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.136113", "ticker_sentiment_score": "0.100859", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.392948", "ticker_sentiment_score": "0.008166", "ticker_sentiment_label": "Neutral"}]}, {"title": "HOOKIPA Pharma Inc.  ( HOOK )  Reports Q2 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/1967056/hookipa-pharma-inc-hook-reports-q2-loss-misses-revenue-estimates", "time_published": "20220811T121509", "authors": ["Zacks Investment Research"], "summary": "HOOKIPA Pharma Inc. (HOOK) delivered earnings and revenue surprises of 36.11% and 21.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default361.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.103466, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.136113", "ticker_sentiment_score": "0.103274", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOK", "relevance_score": "0.392948", "ticker_sentiment_score": "0.008164", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aveanna Healthcare  ( AVAH )  Q2 Earnings and Revenues Miss Estimates", "url": "https://www.zacks.com/stock/news/1966954/aveanna-healthcare-avah-q2-earnings-and-revenues-miss-estimates", "time_published": "20220811T002502", "authors": ["Zacks Investment Research"], "summary": "Aveanna (AVAH) delivered earnings and revenue surprises of -50% and 3.03%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default48.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.155887, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.135729", "ticker_sentiment_score": "0.095889", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.135729", "ticker_sentiment_score": "0.186465", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CytomX Therapeutics  ( CTMX )  Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/1964263/cytomx-therapeutics-ctmx-reports-q2-loss-lags-revenue-estimates", "time_published": "20220804T214514", "authors": ["Zacks Investment Research"], "summary": "CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -2.78% and 1.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default153.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.133873, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137671", "ticker_sentiment_score": "0.103896", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.397098", "ticker_sentiment_score": "0.079507", "ticker_sentiment_label": "Neutral"}]}, {"title": "Harmony Biosciences Holdings, Inc.  ( HRMY )  Surpasses Q2 Earnings and Revenue Estimates", "url": "https://www.zacks.com/stock/news/1961938/harmony-biosciences-holdings-inc-hrmy-surpasses-q2-earnings-and-revenue-estimates", "time_published": "20220802T124504", "authors": ["Zacks Investment Research"], "summary": "Harmony Biosciences Holdings, Inc. (HRMY) delivered earnings and revenue surprises of 42.50% and 7.73%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default163.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999992"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.169201, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.134968", "ticker_sentiment_score": "0.135316", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRMY", "relevance_score": "0.389889", "ticker_sentiment_score": "0.166657", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Agricultural Biotechnology Market to Reach US$ 64.7 Bn by 2031, Finds TMR Study", "url": "https://www.prnewswire.com/news-releases/agricultural-biotechnology-market-to-reach-us-64-7-bn-by-2031--finds-tmr-study-301574655.html", "time_published": "20220624T133000", "authors": ["Transparency Market Research"], "summary": "\u2022 R&D in agricultural biotechnology to reinforce the application in improving nutritional value of crops in multiple ways.", "banner_image": "https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.065314, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.032794", "ticker_sentiment_score": "0.010341", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOOG", "relevance_score": "0.032794", "ticker_sentiment_score": "0.002947", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNKZF", "relevance_score": "0.032794", "ticker_sentiment_score": "0.010341", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTVA", "relevance_score": "0.032794", "ticker_sentiment_score": "0.010341", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBCMY", "relevance_score": "0.032794", "ticker_sentiment_score": "0.010341", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article", "time_published": "20220613T161842", "authors": ["Benzinga Insights"], "summary": "During Monday's trading, 1214 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Microsoft MSFT. Quoin Pharmaceuticals QNRX was the smallest company by market cap to set a new 52-week low. DexCom DXCM's stock fell the most, as it traded down 76.5% to ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_10371.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.018781, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CNTG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027909", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.009789", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000109", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.394081", "ticker_sentiment_label": "Bearish"}, {"ticker": "EXAS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006089", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002333", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTGN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005659", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006147", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008999", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.04494", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027053", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004474", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017209", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.002683", "ticker_sentiment_score": "0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.037999", "ticker_sentiment_label": "Neutral"}, {"ticker": "COUP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009823", "ticker_sentiment_label": "Neutral"}, {"ticker": "FARO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002432", "ticker_sentiment_label": "Neutral"}, {"ticker": "INBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019024", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.314549", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.229754", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BOXL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030487", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00374", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005022", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007708", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016249", "ticker_sentiment_label": "Neutral"}, {"ticker": "GROM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUBE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001131", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008257", "ticker_sentiment_label": "Neutral"}, {"ticker": "AP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004327", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008806", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.342178", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004169", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSEC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006633", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.02233", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEGH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006247", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNTCW", "relevance_score": "0.002683", "ticker_sentiment_score": "0.0055", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001487", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011287", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001164", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLOK", "relevance_score": "0.005366", "ticker_sentiment_score": "7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009324", "ticker_sentiment_label": "Neutral"}, {"ticker": "SES", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021897", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000388", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003981", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.041898", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008576", "ticker_sentiment_label": "Neutral"}, {"ticker": "F", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010108", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.003565", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004917", "ticker_sentiment_label": "Neutral"}, {"ticker": "BK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00219", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002581", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001268", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.037181", "ticker_sentiment_label": "Neutral"}, {"ticker": "THC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001967", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.039444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000453", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWBC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACEL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005325", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006309", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004249", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.005366", "ticker_sentiment_score": "-9e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.177272", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HQI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.028836", "ticker_sentiment_label": "Neutral"}, {"ticker": "BXMT", "relevance_score": "0.005366", "ticker_sentiment_score": "3.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001269", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017992", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFGP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002325", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007002", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005908", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFSL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010451", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00184", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.197234", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.107514", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005633", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006145", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-9.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002013", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001482", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013582", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00131", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003307", "ticker_sentiment_label": "Neutral"}, {"ticker": "DD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000957", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002541", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014392", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001189", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011785", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.023485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.017301", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.47679", "ticker_sentiment_label": "Bearish"}, {"ticker": "GPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006787", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015548", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZUL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.018071", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.03994", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007245", "ticker_sentiment_label": "Neutral"}, {"ticker": "NYMT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007944", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005756", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENSC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.174993", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INFY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010375", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004067", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002323", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNDM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001063", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010741", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009463", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015382", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDWR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.080194", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0088", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001972", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009282", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRMB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022412", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008283", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000178", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002374", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006113", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00144", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002664", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000298", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.371182", "ticker_sentiment_label": "Bearish"}, {"ticker": "SIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019862", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013209", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPRO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.104865", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007895", "ticker_sentiment_label": "Neutral"}, {"ticker": "FN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000843", "ticker_sentiment_label": "Neutral"}, {"ticker": "UNB", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "STWD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002531", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.006072", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNGX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.049879", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSFT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.038976", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0102", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.044669", "ticker_sentiment_label": "Neutral"}, {"ticker": "CION", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0047", "ticker_sentiment_label": "Neutral"}, {"ticker": "GE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.346341", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCCC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001494", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000903", "ticker_sentiment_label": "Neutral"}, {"ticker": "DMTK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003168", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBLU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005037", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.242942", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SSSS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000192", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004607", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLZE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004558", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.005083", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013405", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003042", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSTK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013694", "ticker_sentiment_label": "Neutral"}, {"ticker": "VBIV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002076", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.050455", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000857", "ticker_sentiment_label": "Neutral"}, {"ticker": "HA", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.003169", "ticker_sentiment_label": "Neutral"}, {"ticker": "RICK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003331", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008186", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012919", "ticker_sentiment_label": "Neutral"}, {"ticker": "UMBF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.033109", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENTG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003676", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIII", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009225", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007906", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00294", "ticker_sentiment_label": "Neutral"}, {"ticker": "SONX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003236", "ticker_sentiment_label": "Neutral"}, {"ticker": "CABA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.073546", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00055", "ticker_sentiment_label": "Neutral"}, {"ticker": "OXLC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003855", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.010731", "ticker_sentiment_score": "0.056798", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOUR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014221", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006197", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.212204", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGHT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007331", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014763", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003835", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013876", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001742", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCBO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002769", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013135", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000152", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003007", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006871", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.001137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002906", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00204", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003766", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGAL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.019917", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.002683", "ticker_sentiment_score": "0.0045", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002285", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007485", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002977", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030157", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01473", "ticker_sentiment_label": "Neutral"}, {"ticker": "OEG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003312", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZIMV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001842", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTOL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005648", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013855", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005093", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.041687", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERJ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.0094", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBGI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006823", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001436", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVER", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00895", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.018778", "ticker_sentiment_score": "0.001179", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008479", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBIG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004566", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003902", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008305", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.010138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00371", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004256", "ticker_sentiment_label": "Neutral"}, {"ticker": "URI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002609", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASML", "relevance_score": "0.005366", "ticker_sentiment_score": "0.0051", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000932", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003728", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017667", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002149", "ticker_sentiment_label": "Neutral"}, {"ticker": "KB", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.010525", "ticker_sentiment_label": "Neutral"}, {"ticker": "GWH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006451", "ticker_sentiment_label": "Neutral"}, {"ticker": "COF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000213", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBCI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005604", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008957", "ticker_sentiment_label": "Neutral"}, {"ticker": "MBIO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005515", "ticker_sentiment_label": "Neutral"}, {"ticker": "SATL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006127", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUAD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.038077", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCFC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002964", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFRI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00759", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005261", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000143", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.002683", "ticker_sentiment_score": "0.001132", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOSS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01457", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.002683", "ticker_sentiment_score": "0.008572", "ticker_sentiment_label": "Neutral"}, {"ticker": "XYL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.055113", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001097", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001493", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006709", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01114", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016704", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004563", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTMD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007197", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00283", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01399", "ticker_sentiment_label": "Neutral"}, {"ticker": "LE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.298506", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NEO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00126", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "NET", "relevance_score": "0.005366", "ticker_sentiment_score": "0.034025", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014023", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBTX", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.172639", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.04368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAW", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004566", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007224", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012256", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRAA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005135", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020627", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPER", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013746", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013786", "ticker_sentiment_label": "Neutral"}, {"ticker": "NHTC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.026834", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006603", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002043", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013974", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030374", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.057433", "ticker_sentiment_label": "Neutral"}, {"ticker": "AME", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001235", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010887", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005912", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021861", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACON", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005292", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002632", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROVR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00612", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001002", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.276654", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UNIT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005813", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.035506", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024766", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALBO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002894", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.011699", "ticker_sentiment_label": "Neutral"}, {"ticker": "MU", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011682", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010378", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001984", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVNO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007961", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.022522", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003053", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003861", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001654", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010093", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMRE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003212", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.003976", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017414", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001716", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.28098", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MGTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008235", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024331", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRLD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.250534", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMCX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008317", "ticker_sentiment_label": "Neutral"}, {"ticker": "NN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.051327", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001001", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004653", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSEC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00902", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.015", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.136277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPE", "relevance_score": "0.005366", "ticker_sentiment_score": "4e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.04472", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000672", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006213", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009636", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009216", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006137", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017906", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002249", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPR", "relevance_score": "0.008048", "ticker_sentiment_score": "0.001455", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCLH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.282133", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LBPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005701", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTIS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002654", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.253696", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLDR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.031864", "ticker_sentiment_label": "Neutral"}, {"ticker": "DVA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009077", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010008", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRMK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007329", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002994", "ticker_sentiment_label": "Neutral"}, {"ticker": "PH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000173", "ticker_sentiment_label": "Neutral"}, {"ticker": "PK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.026715", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000458", "ticker_sentiment_label": "Neutral"}, {"ticker": "RUBY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00549", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTDR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.289087", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FXLV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000102", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.024476", "ticker_sentiment_label": "Neutral"}, {"ticker": "APO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005626", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIAV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005501", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.034935", "ticker_sentiment_label": "Neutral"}, {"ticker": "XSPA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003054", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.029459", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "STM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.26252", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GSBD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005083", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.030902", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00391", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012266", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUK", "relevance_score": "0.002683", "ticker_sentiment_score": "0.029025", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZENV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003257", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003011", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003282", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005966", "ticker_sentiment_label": "Neutral"}, {"ticker": "QS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003825", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLAB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.065602", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006692", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGNY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.033419", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUNE", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027877", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008994", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013387", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORGO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002621", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000994", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007866", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLYM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.17614", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SNTI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008436", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWOD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001806", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007939", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRSK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001025", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTFT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00147", "ticker_sentiment_label": "Neutral"}, {"ticker": "KEY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006956", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.044451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002691", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014395", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTTR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.05491", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.035328", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.014448", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000107", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLYW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.280495", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TXN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004765", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002255", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00155", "ticker_sentiment_label": "Neutral"}, {"ticker": "FITB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00525", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006384", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.167193", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.023907", "ticker_sentiment_label": "Neutral"}, {"ticker": "SG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.101005", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.426684", "ticker_sentiment_label": "Bearish"}, {"ticker": "NLY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.018267", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002427", "ticker_sentiment_label": "Neutral"}, {"ticker": "KFY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKNO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.013786", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002735", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.050893", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002399", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000644", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFET", "relevance_score": "0.005366", "ticker_sentiment_score": "0.0403", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01828", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000404", "ticker_sentiment_label": "Neutral"}, {"ticker": "SILC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003704", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000847", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004694", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003456", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPEN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005675", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006552", "ticker_sentiment_label": "Neutral"}, {"ticker": "VATE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004868", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZNP", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001317", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.03375", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIOT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015914", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPMC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.013229", "ticker_sentiment_label": "Neutral"}, {"ticker": "DESP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003244", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011817", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01245", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009317", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015156", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00235", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMKR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017984", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "AQST", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.046567", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008791", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.028722", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007241", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.005366", "ticker_sentiment_score": "0.023575", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.040438", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00893", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMFC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.02795", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.017094", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005889", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLDX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003648", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003256", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTRS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015322", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003469", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005381", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.002958", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007964", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000464", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNHI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014746", "ticker_sentiment_label": "Neutral"}, {"ticker": "KORE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.017331", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "INVH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006232", "ticker_sentiment_label": "Neutral"}, {"ticker": "NDSN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014258", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.021784", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBDC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007026", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004191", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001847", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01029", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBLA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004869", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008775", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001806", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00297", "ticker_sentiment_label": "Neutral"}, {"ticker": "UHID", "relevance_score": "0.002683", "ticker_sentiment_score": "0.006598", "ticker_sentiment_label": "Neutral"}, {"ticker": "POET", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000856", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWIN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.09399", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003517", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000764", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARWR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000431", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00341", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006057", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCBP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005028", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.036964", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.106035", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01838", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIPO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.018148", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDXG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006081", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000186", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004032", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYN", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.004229", "ticker_sentiment_label": "Neutral"}, {"ticker": "STER", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.037725", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01307", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014019", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004274", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.002683", "ticker_sentiment_score": "0.035061", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.410902", "ticker_sentiment_label": "Bearish"}, {"ticker": "BZH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011111", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003768", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007762", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002945", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005683", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRHC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.016485", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQIX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.005366", "ticker_sentiment_score": "0.008322", "ticker_sentiment_label": "Neutral"}, {"ticker": "REKR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014413", "ticker_sentiment_label": "Neutral"}, {"ticker": "LNC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001112", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.047866", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZFD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011203", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRMW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000353", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWKS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.022588", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBWI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.060782", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.177137", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KLR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006762", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.034866", "ticker_sentiment_score": "0.006675", "ticker_sentiment_label": "Neutral"}, {"ticker": "FERG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.214254", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MPW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000688", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLED", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009965", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016238", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBTX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.043124", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETZ", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003573", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.032893", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000512", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006642", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001026", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.017825", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.064589", "ticker_sentiment_label": "Neutral"}, {"ticker": "TY-P", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.006567", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.010323", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.079529", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003508", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.092696", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.030029", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.031876", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.012851", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.292681", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FRME", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002489", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006409", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00436", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGTI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.010966", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZR", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002149", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESRT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006306", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.01173", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.038416", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRUS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003047", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANSS", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007534", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNAZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027316", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.016507", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCMG", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00216", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00426", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBGI", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003944", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNMD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.00816", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.147209", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBP", "relevance_score": "0.002683", "ticker_sentiment_score": "5.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.285853", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DBRG-P-I", "relevance_score": "0.002683", "ticker_sentiment_score": "0.011535", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDSB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005046", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005913", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000958", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRX", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020239", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022321", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00424", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003463", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.003073", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005686", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYNT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.058627", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009997", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004248", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.020459", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002649", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAVI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000292", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001094", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVBF", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001092", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007576", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001048", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFF", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.009866", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.457779", "ticker_sentiment_label": "Bearish"}, {"ticker": "VSAT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001534", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011298", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007243", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001505", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001096", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.217102", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BLND", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006675", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENIA", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIB", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000218", "ticker_sentiment_label": "Neutral"}, {"ticker": "DATS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000151", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001912", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITIC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.015091", "ticker_sentiment_label": "Neutral"}, {"ticker": "GIL", "relevance_score": "0.005366", "ticker_sentiment_score": "0.009558", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.012286", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007896", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLLS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.007774", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQOS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012653", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.076716", "ticker_sentiment_label": "Neutral"}, {"ticker": "FFWM", "relevance_score": "0.005366", "ticker_sentiment_score": "0.004455", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYGN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011165", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006705", "ticker_sentiment_label": "Neutral"}, {"ticker": "TACT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.287375", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TREE", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006545", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.006116", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGRY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.011411", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASAN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.011856", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001405", "ticker_sentiment_label": "Neutral"}, {"ticker": "OZK", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000702", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMDA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.01837", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000777", "ticker_sentiment_label": "Neutral"}, {"ticker": "PARA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007437", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.022206", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNTV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.185813", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WIX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006554", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.014567", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGFV", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033718", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.005366", "ticker_sentiment_score": "0.021183", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.072571", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNQ", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005018", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.245399", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VKTX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033916", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGIO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.019831", "ticker_sentiment_label": "Neutral"}, {"ticker": "LJPC", "relevance_score": "0.008048", "ticker_sentiment_score": "-0.048285", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.033555", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.005366", "ticker_sentiment_score": "0.005318", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIGI", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.000392", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMRN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.001128", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTEX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006763", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVAX", "relevance_score": "0.005366", "ticker_sentiment_score": "0.006605", "ticker_sentiment_label": "Neutral"}, {"ticker": "STOK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.062872", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXCM", "relevance_score": "0.002683", "ticker_sentiment_score": "0.047017", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.005366", "ticker_sentiment_score": "0.001794", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAC", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.040702", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.005366", "ticker_sentiment_score": "0.000426", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMN", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.310839", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NYT", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.027556", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.254871", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCK", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003342", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRMN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.034094", "ticker_sentiment_label": "Neutral"}, {"ticker": "AINV", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.008496", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCS", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.002725", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.531702", "ticker_sentiment_label": "Bearish"}, {"ticker": "KTB", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.004746", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.012133", "ticker_sentiment_label": "Neutral"}, {"ticker": "USFD", "relevance_score": "0.005366", "ticker_sentiment_score": "-0.005066", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRNA", "relevance_score": "0.005366", "ticker_sentiment_score": "0.007569", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.005366", "ticker_sentiment_score": "0.00738", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:GBP", "relevance_score": "0.002683", "ticker_sentiment_score": "-0.037725", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Q1 Revenue Decreases 28.82% YoY, What About Debt?", "url": "https://www.benzinga.com/markets/cannabis/22/05/27415166/evogene-q1-2022-revenue-decreases-28-82-yoy-what-about-bank-debt", "time_published": "20220526T124138", "authors": ["Vuk Zdinjak"], "summary": "Evogene Ltd. ( NASDAQ: EVGN ) ( TASE:EVGN ) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the previous year. Q1 Financial Highlights The net loss for the quarter was $9.1 million in comparison", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/26/louis-reed-pwckf7l4-no-unsplash.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.001294, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.371523", "ticker_sentiment_score": "0.036229", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( EVGN )  Reports Q1 Loss, Lags Revenue Estimates", "url": "https://www.zacks.com/stock/news/1929497/evogene-evgn-reports-q1-loss-lags-revenue-estimates", "time_published": "20220526T122505", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of -42.86% and 46.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default170.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.067488, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.375816", "ticker_sentiment_score": "-0.09298", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.193516", "ticker_sentiment_score": "-0.126429", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene Reports First Quarter 2022 Financial Results", "url": "https://www.prnewswire.com/il/news-releases/evogene-reports-first-quarter-2022-financial-results-301555738.html", "time_published": "20220526T110000", "authors": ["Evogene"], "summary": "Conference call and webcast: today, May 26, 2022, 9:00 am ET", "banner_image": "https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.064172, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.242793", "ticker_sentiment_score": "0.068843", "ticker_sentiment_label": "Neutral"}]}, {"title": "Earnings Scheduled For May 26, 2022", "url": "https://www.benzinga.com/news/earnings/22/05/27411722/earnings-scheduled-for-may-26-2022", "time_published": "20220526T090941", "authors": ["Benzinga Insights"], "summary": "Companies Reporting Before The Bell \u2022 American Woodmark ( NASDAQ:AMWD ) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million. \u2022 Evogene ( NASDAQ:EVGN ) is estimated to report earnings for its first quarter. \u2022 Alibaba Group Holding ( NYSE:BABA ) is likely to r", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/earnings_image_6867.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.023716, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VMW", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.00831", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.002447", "ticker_sentiment_label": "Neutral"}, {"ticker": "TITN", "relevance_score": "0.071549", "ticker_sentiment_score": "0.000181", "ticker_sentiment_label": "Neutral"}, {"ticker": "GPS", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.11824", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.403082", "ticker_sentiment_label": "Bearish"}, {"ticker": "FANH", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.019316", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.071549", "ticker_sentiment_score": "0.001032", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.03581", "ticker_sentiment_score": "-0.124676", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNSO", "relevance_score": "0.071549", "ticker_sentiment_score": "0.001672", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.071549", "ticker_sentiment_score": "0.001714", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDT", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.004291", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKE", "relevance_score": "0.071549", "ticker_sentiment_score": "0.000748", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.071549", "ticker_sentiment_score": "0.00035", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.058291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADSK", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.002112", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLTR", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.051032", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAXN", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.092952", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.071549", "ticker_sentiment_score": "0.001697", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXLG", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.001007", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZS", "relevance_score": "0.071549", "ticker_sentiment_score": "0.005373", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNF", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.006243", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.017531", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.058268", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPG", "relevance_score": "0.071549", "ticker_sentiment_score": "0.001232", "ticker_sentiment_label": "Neutral"}, {"ticker": "RY", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.000329", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.025249", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTOO", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.002097", "ticker_sentiment_label": "Neutral"}, {"ticker": "M", "relevance_score": "0.03581", "ticker_sentiment_score": "-0.002447", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGF-A", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.042585", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIZI", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.009621", "ticker_sentiment_label": "Neutral"}, {"ticker": "BURL", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.000561", "ticker_sentiment_label": "Neutral"}, {"ticker": "COST", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.005399", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROLL", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.00127", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.005231", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGRU", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.000584", "ticker_sentiment_label": "Neutral"}, {"ticker": "THR", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.000158", "ticker_sentiment_label": "Neutral"}, {"ticker": "CD", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.002588", "ticker_sentiment_label": "Neutral"}, {"ticker": "ULTA", "relevance_score": "0.071549", "ticker_sentiment_score": "0.002897", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWD", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.001845", "ticker_sentiment_label": "Neutral"}, {"ticker": "KUKE", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.031689", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.071549", "ticker_sentiment_score": "9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDAY", "relevance_score": "0.071549", "ticker_sentiment_score": "0.000328", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZUN", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.003624", "ticker_sentiment_label": "Neutral"}, {"ticker": "TD", "relevance_score": "0.071549", "ticker_sentiment_score": "0.001897", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRC", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.001625", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCO", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.024067", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOV", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.000796", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.013613", "ticker_sentiment_label": "Neutral"}, {"ticker": "MANU", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.072836", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVL", "relevance_score": "0.071549", "ticker_sentiment_score": "-0.003703", "ticker_sentiment_label": "Neutral"}, {"ticker": "JACK", "relevance_score": "0.071549", "ticker_sentiment_score": "0.000684", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLNG", "relevance_score": "0.071549", "ticker_sentiment_score": "0.000176", "ticker_sentiment_label": "Neutral"}]}, {"title": "Vascular Biogenics  ( VBLT )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/1925192/vascular-biogenics-vblt-reports-q1-loss-misses-revenue-estimates", "time_published": "20220517T121507", "authors": ["Zacks Investment Research"], "summary": "Vascular Biogenics (VBLT) delivered earnings and revenue surprises of -8.33% and 42.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default191.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.054589, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.127524", "ticker_sentiment_score": "-0.296221", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VBLT", "relevance_score": "0.369868", "ticker_sentiment_score": "-0.101186", "ticker_sentiment_label": "Neutral"}]}, {"title": "Syros Pharmaceuticals, Inc.  ( SYRS )  Reports Q1 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/1924603/syros-pharmaceuticals-inc-syrs-reports-q1-loss-tops-revenue-estimates", "time_published": "20220516T124503", "authors": ["Zacks Investment Research"], "summary": "Syros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of 16.67% and 20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default171.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999759"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.038958, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.125199", "ticker_sentiment_score": "-0.316936", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SYRS", "relevance_score": "0.418689", "ticker_sentiment_score": "-0.014803", "ticker_sentiment_label": "Neutral"}]}, {"title": "Fortress Biotech  ( FBIO )  Reports Q1 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/1923607/fortress-biotech-fbio-reports-q1-loss-tops-revenue-estimates", "time_published": "20220512T213513", "authors": ["Zacks Investment Research"], "summary": "Fortress Biotech (FBIO) delivered earnings and revenue surprises of 35.71% and 19.27%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default98.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999892"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.041451, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.12749", "ticker_sentiment_score": "-0.316936", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FBIO", "relevance_score": "0.369776", "ticker_sentiment_score": "-0.049865", "ticker_sentiment_label": "Neutral"}]}, {"title": "Tarsus Pharmaceuticals, Inc.  ( TARS )  Reports Q1 Loss, Misses Revenue Estimates", "url": "https://www.zacks.com/stock/news/1922347/tarsus-pharmaceuticals-inc-tars-reports-q1-loss-misses-revenue-estimates", "time_published": "20220510T225506", "authors": ["Zacks Investment Research"], "summary": "Tarsus Pharmaceuticals, Inc. (TARS) delivered earnings and revenue surprises of -12.64% and 90.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default39.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999892"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.039746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.126617", "ticker_sentiment_score": "-0.55077", "ticker_sentiment_label": "Bearish"}, {"ticker": "TARS", "relevance_score": "0.422998", "ticker_sentiment_score": "-0.006208", "ticker_sentiment_label": "Neutral"}]}, {"title": "26 Stocks Moving in Thursday's Pre-Market Session", "url": "https://www.benzinga.com/news/22/04/26731920/26-stocks-moving-in-thursdays-pre-market-session", "time_published": "20220421T102236", "authors": [], "summary": "Gainers\nRedbox Entertainment Inc.   ( NASDAQ: RDBX )  rose 31.9% to $3.35 in pre-market trading after jumping around 25% on Wednesday.\nClarus Therapeutics Holdings, Inc.  ( NASDAQ: CRXT )  shares rose 18.7% to $2.47 in pre-market trading after climbing over 43% on Wednesday. The company on Tuesday a", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/21/premkt_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.94309"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.891286"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.018787, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AA", "relevance_score": "0.101992", "ticker_sentiment_score": "-0.004383", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVR", "relevance_score": "0.051101", "ticker_sentiment_score": "-0.002205", "ticker_sentiment_label": "Neutral"}, {"ticker": "UAL", "relevance_score": "0.152467", "ticker_sentiment_score": "0.015702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.051101", "ticker_sentiment_score": "0.011968", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.152467", "ticker_sentiment_score": "0.00813", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXGL", "relevance_score": "0.152467", "ticker_sentiment_score": "0.000397", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAL", "relevance_score": "0.101992", "ticker_sentiment_score": "0.000284", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTX", "relevance_score": "0.152467", "ticker_sentiment_score": "0.002719", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.101992", "ticker_sentiment_score": "-0.210909", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MULN", "relevance_score": "0.101992", "ticker_sentiment_score": "0.000573", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.101992", "ticker_sentiment_score": "0.001315", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.101992", "ticker_sentiment_score": "0.000314", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYLN", "relevance_score": "0.152467", "ticker_sentiment_score": "0.00272", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLT", "relevance_score": "0.152467", "ticker_sentiment_score": "0.013881", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.101992", "ticker_sentiment_score": "0.037577", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.101992", "ticker_sentiment_score": "0.011968", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFX", "relevance_score": "0.101992", "ticker_sentiment_score": "-0.002205", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.101992", "ticker_sentiment_score": "0.000942", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.152467", "ticker_sentiment_score": "0.001723", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTK", "relevance_score": "0.101992", "ticker_sentiment_score": "0.02756", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTC", "relevance_score": "0.101992", "ticker_sentiment_score": "0.000907", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATER", "relevance_score": "0.152467", "ticker_sentiment_score": "0.000438", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.152467", "ticker_sentiment_score": "-0.045491", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene  ( EVGN )  Reports Q4 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/1880132/evogene-evgn-reports-q4-loss-tops-revenue-estimates", "time_published": "20220310T134503", "authors": ["Zacks Investment Research"], "summary": "Evogene (EVGN) delivered earnings and revenue surprises of 10% and 107.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default121.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.995869"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.064036, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.375722", "ticker_sentiment_score": "-0.020475", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.193465", "ticker_sentiment_score": "-0.15384", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Evogene Reports Wider Loss In 2021, $54M In Consolidated Cash", "url": "https://www.benzinga.com/markets/cannabis/22/03/26078672/evogene-reports-wider-loss-in-2021-54m-in-consolidated-cash", "time_published": "20220310T125320", "authors": ["Jelena Martinovic"], "summary": "Evogene Ltd.  ( NASDAQ: EVGN )   ( TASE: EVGN )  announced its financial results for the fourth quarter and full year of 2021, ended December 31, 2021.\nQ4 Financial Highlights\nConsolidated cash usage was approximately $8.4 million, or $7 million, excluding Lavie Bio compared to roughly $6.1 million,", "banner_image": "https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/markus-winkler-irrbsnd5euc-unsplash25.jpg?width=720", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.001668, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.137829", "ticker_sentiment_score": "0.001668", "ticker_sentiment_label": "Neutral"}]}, {"title": "Earnings Scheduled For March 10, 2022", "url": "https://www.benzinga.com/news/earnings/22/03/26075023/earnings-scheduled-for-march-10-2022", "time_published": "20220310T093327", "authors": [], "summary": "Companies Reporting Before The Bell\n\u2022 Despegar.com  ( NYSE:DESP )  is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million.\n\u2022 ProShares UltraShort Russell2000  ( NYSE:TWM )  is expected to report earnings for its fourth quarter.\n\u2022 Vivid Seats  ( NASDAQ:SEAT )  is projec", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/earnings_image_2641.jpeg", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.025917, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZUMZ", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001885", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEIM", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.040365", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCEL", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.055084", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.03586", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.093725", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTOS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.006179", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.014477", "ticker_sentiment_score": "0.002634", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCBO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.020982", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBW", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000807", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.018136", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.046268", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYE", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000205", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOCU", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001317", "ticker_sentiment_label": "Neutral"}, {"ticker": "ECOR", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.02628", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNE-P-A", "relevance_score": "0.014477", "ticker_sentiment_score": "0.005004", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.011695", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.199717", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "III", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000109", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSQR", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.008399", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLXE", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.126522", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.0148", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOI", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.022582", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.015567", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLDN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.002265", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHLD", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPH", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000805", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRIX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.008232", "ticker_sentiment_label": "Neutral"}, {"ticker": "JD", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001823", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXMD", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.107637", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.036379", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSEA", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.002258", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPFI", "relevance_score": "0.014477", "ticker_sentiment_score": "0.00017", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.040391", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.06455", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.038862", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRE", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001354", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIZI", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.053098", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOUT", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000382", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.016277", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.010423", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGLS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.014179", "ticker_sentiment_label": "Neutral"}, {"ticker": "CD", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.002109", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRAP", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.024793", "ticker_sentiment_label": "Neutral"}, {"ticker": "ULTA", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000164", "ticker_sentiment_label": "Neutral"}, {"ticker": "URGN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.055175", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSD", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000233", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRAG", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.003454", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.011445", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYTO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.019344", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.014471", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRDN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.060415", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRVS", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000794", "ticker_sentiment_label": "Neutral"}, {"ticker": "TH", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.067596", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.143318", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFST", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.072974", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000118", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLRX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.036608", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEL", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.00123", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZN", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000645", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.00098", "ticker_sentiment_label": "Neutral"}, {"ticker": "NPCE", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.039682", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTMN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000426", "ticker_sentiment_label": "Neutral"}, {"ticker": "RERE", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.056481", "ticker_sentiment_label": "Neutral"}, {"ticker": "DESP", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.017737", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.003575", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATY", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.04088", "ticker_sentiment_label": "Neutral"}, {"ticker": "CANG", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000162", "ticker_sentiment_label": "Neutral"}, {"ticker": "DXYN", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000747", "ticker_sentiment_label": "Neutral"}, {"ticker": "LZ", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.019075", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVGS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.002205", "ticker_sentiment_label": "Neutral"}, {"ticker": "EDR", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPM", "relevance_score": "0.014477", "ticker_sentiment_score": "7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.042302", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.03128", "ticker_sentiment_label": "Neutral"}, {"ticker": "THRY", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.133489", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.007082", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSP", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.022298", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.054652", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.014477", "ticker_sentiment_score": "0.001087", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNOP", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000346", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGBL", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORCL", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.005993", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTRU", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHV", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.01196", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMTX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.058989", "ticker_sentiment_label": "Neutral"}, {"ticker": "EIGR", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.044944", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000302", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUTL", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.041986", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBCP", "relevance_score": "0.014477", "ticker_sentiment_score": "0.00018", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSQ", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000346", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCP", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.017598", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.00048", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.019129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLNK", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001122", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBLI", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.086234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVO", "relevance_score": "0.014477", "ticker_sentiment_score": "0.000191", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000375", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.017283", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENG", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.091565", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPH", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.004227", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAPA", "relevance_score": "0.014477", "ticker_sentiment_score": "-9.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTH", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.041898", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNEV", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.035177", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.007244", "ticker_sentiment_label": "Neutral"}, {"ticker": "XERS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.076799", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUMO", "relevance_score": "0.014477", "ticker_sentiment_score": "0.001192", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVOX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.031433", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRT", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.034052", "ticker_sentiment_label": "Neutral"}, {"ticker": "CION", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.006908", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLTH", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001453", "ticker_sentiment_label": "Neutral"}, {"ticker": "QFIN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFIB", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.010974", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIPO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.015306", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.014477", "ticker_sentiment_score": "0.002341", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.03229", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTRN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.054832", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.031421", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZUN", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.00082", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCO", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.000189", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.042969", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPO", "relevance_score": "0.014477", "ticker_sentiment_score": "-8.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.035309", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTO", "relevance_score": "0.014477", "ticker_sentiment_score": "3.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVT", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.001122", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXK", "relevance_score": "0.014477", "ticker_sentiment_score": "-3.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCLP", "relevance_score": "0.014477", "ticker_sentiment_score": "1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAPR", "relevance_score": "0.014477", "ticker_sentiment_score": "-0.021354", "ticker_sentiment_label": "Neutral"}]}, {"title": "Evogene to Attend to World Agri-Tech Innovation Summit from March 22-23, 2022", "url": "https://www.prnewswire.com/news-releases/evogene-to-attend-to-world-agri-tech-innovation-summit-from-march-22-23-2022-301496551.html", "time_published": "20220307T120000", "authors": ["Evogene"], "summary": "REHOVOT, Israel, March 7, 2022 /PRNewswire/ -- Evogene Ltd.  ( NASDAQ: EVGN )   ( TASE: EVGN ) , a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, today announced that it will be attending the World Agri-Tech Innovation Summit from March 22-23, 2022 in San Francisco.", "banner_image": "https://mma.prnewswire.com/media/890385/Evogene_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.052965, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVGN", "relevance_score": "0.716453", "ticker_sentiment_score": "0.047151", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGTEF", "relevance_score": "0.106636", "ticker_sentiment_score": "0.092016", "ticker_sentiment_label": "Neutral"}]}]}